Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals adopted a new shareholder rights plan (poison pill) effective October 6, 2026, to protect its net operating loss carryforwards (NOLs) and other tax benefits. The plan allows existing shareholders to purchase additional shares at a discount if any person or group acquires 4.99% or more of the company's common stock, thereby deterring hostile takeovers.…more
Sonoma Pharmaceuticals, Inc.
On October 6, 2026, Sonoma Pharmaceuticals adopted a new Section 382 Rights Agreement (poison pill) to protect its net operating loss carryforwards (NOLs). Shareholders of record as of October 13 will receive one preferred stock purchase right per share, which triggers if any person acquires 4.99% or more of the company's common stock.…more
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals cancelled its special meeting of stockholders on August 19, 2026, due to a failure to achieve a quorum. The company has decided not to solicit additional proxies, resulting in the termination of the meeting.…more
4 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
No news collected yet. New articles will appear here.